The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer

OBJECTIVE: To report outcomes and toxicity in patients who received definitive concurrent chemoradiation (DCCRT) for non‐operable esophageal cancer (EC) in the modern era, and to identify markers of overall and disease‐free survival (OS/DFS). METHODS: We conducted a retrospective cohort study of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreyfuss, Alexandra D., Barsky, Andrew R., Wileyto, E. Paul, Eads, Jennifer R., Kucharczuk, John C., Williams, Noel N., Karasic, Thomas B., Metz, James M., Ben‐Josef, Edgar, Plastaras, John P., Wojcieszynski, Andrzej P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926027/
https://www.ncbi.nlm.nih.gov/pubmed/33474812
http://dx.doi.org/10.1002/cam4.3724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926027/
https://www.ncbi.nlm.nih.gov/pubmed/33474812
http://dx.doi.org/10.1002/cam4.3724

Ejemplares similares